Thyroid Cancer Trial, Recruiting (NCT07140757)

Thyroid Cancer Trial, Recruiting NCT07140757 Sponsor: M.D. Anderson Cancer Center Condition: Thyroid Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07140757 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Thyroid Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are scheduled to have a procedure called radiofrequency ablation (RFA) — a heat-based treatment guided by ultrasound — for a thyroid condition
People who are over 18 years old and are either not suitable for surgery or have chosen not to have surgery
People who are willing and able to sign a written consent form
People who have one of the following confirmed diagnoses:
- A non-cancerous thyroid nodule (confirmed by biopsy) that is causing pressure symptoms or cosmetic concerns, and where treatment has been requested
- A thyroid nodule (confirmed by biopsy) that came back as "indeterminate" — meaning the results were unclear and could not confirm whether it is benign or cancerous (confirm with trial site)
- A type of thyroid cancer called papillary thyroid carcinoma (PTC) that has not spread to other parts of the body
- Thyroid cancer that has come back in the same area and is smaller than 2 cm

Who may not be able to join:

People whose treating doctor considers them unsuitable for the RFA procedure for any reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Victoria E Banuchi, MD, M.D. Anderson Cancer Center

Phone: 346-217-8668

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07140757

Sponsor: M.D. Anderson Cancer Center

Phase: Not Applicable

Status: Recruiting

Condition: Thyroid Cancer

Trial contact: 346-217-8668

More information: https://clinicaltrials.gov/study/NCT07140757

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are scheduled to have a procedure called radiofrequency ablation (RFA) — a heat-based treatment guided by ultrasound — for a thyroid condition
People who are over 18 years old and are either not suitable for surgery or have chosen not to have surgery
People who are willing and able to sign a written consent form
People who have one of the following confirmed diagnoses:
- A non-cancerous thyroid nodule (confirmed by biopsy) that is causing pressure symptoms or cosmetic concerns, and where treatment has been requested
- A thyroid nodule (confirmed by biopsy) that came back as "indeterminate" — meaning the results were unclear and could not confirm whether it is benign or cancerous (confirm with trial site)
- A type of thyroid cancer called papillary thyroid carcinoma (PTC) that has not spread to other parts of the body
- Thyroid cancer that has come back in the same area and is smaller than 2 cm

Who may not be able to join:

People whose treating doctor considers them unsuitable for the RFA procedure for any reason

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

M.D. Anderson Cancer Center

Registry

ClinicalTrials.gov

Start date

18 August 2025

Est. completion

31 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Health- related Quality of Life Questionnaires

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov